Smith & Nephew hobbled by Europe
1st Nov 2012 14:12
Global medical technology business Smith & Nephew experienced hard times in Europe in the third quarter and expects these to continue. Revenue in the three months to September 29th was up an underlying 1% but down an actual 7.8% at $952m from $1,032m the year before. Profit before tax eased to $188
Read moreMonday broker round-up
29th Oct 2012 08:10
African Barrick Gold: HSBC cuts target from 710p to 670p, overweight rating kept. African Eagle Resources: Seymour Pierce keeps buy rating. Anglo American: Nomura cuts target from 2,100p to 2,000p, neutral rating kept; UBS ups target from 2,230p to 2,250p, buy rating kept. Burberry: Goldman Sachs
Read moreWeek ahead: Banking results and election fever to take centre-stage
26th Oct 2012 09:08
Next week is set to be an extremely busy week, looking at the corporate and economic calendar from home and abroad. Third-quarter UK corporate earnings season really gets into full swing with some heavyweight Footsie constituents scheduled to report, including GlaxoSmithKline, Shell, Smith & Nephew
Read moreFTSE 100 movers: Burberry rises on signs of improved trading
11th Oct 2012 15:35
Shares in stock market darling Burberry, the luxury fashion chain, leapt on Thursday, after it said its situation had started to improve towards the end of the July-September quarter, during which time sales growth in its stores slowed dramatically, as expected. LFL sales over the half-year were u
Read moreLondon midday: Banking stocks gain, yet Footsie falls
10th Oct 2012 11:32
- IMF warns about Eurozone crisis - Unions call for strikes in Greece - Banks gain on speculation of eased capital rules UK stocks suffered more losses on Wednesday in spite of some relative strength in the banking sector, as the International Monetary Fund (IMF) warned about the risks emanating f
Read moreLondon open: Stocks fall on growth concerns again
10th Oct 2012 08:45
- Growth concerns take down stocks again - Alcoa trims demand forecast - Banks could need to shrink assets, says IMF The FTSE 100 was heading for its third consecutive day in the red, starting Wednesday's session on the back foot with global growth concerns continuing to weigh on sentiment. Trader
Read moreWednesday broker round-up - UDPATE
10th Oct 2012 08:22
African Barrick Gold: Nomura cuts target from 670p to 605p, buy rating kept. APR Energy: JPMorgan Cazenove initiates coverage with overweight rating and 1,005p target. ARM Holdings: Credit Suisse initiates coverage at neutral. ASOS: Seymour Pierce keeps hold rating and 1,900p target. Avanti Com
Read moreWednesday broker round-up - UPDATE
3rd Oct 2012 09:06
African Barrick Gold: Westhouse Secuirites raises target from 464p to 495p. AG Barr: Panmure Gordon keeps hold rating and 440p target. AstraZeneca: Panmure Gordon downgrades from buy to hold, target cut from 3,100p to 3,000p. Barclays: UBS downgrades from buy to neutral, 235p target unchanged. B
Read moreLondon midday: China worries weigh
17th Sep 2012 11:47
China is weighing on UK investors' minds as speculation mounts that the Chinese authorities might not spring into action to juice up the world's second largest economy as quickly as previously thought. Adding weight to that view is the decision by economists at Citigroup to cut their forecast for
Read moreLondon open: Footsie dips below 5900, as China worries simmer
17th Sep 2012 08:23
UK stocks have opened on the back foot with traders agitating over possible delays to the Eurozone´s plans for a banking union, as Germany calls for a more measured approach and a slower pace. Also weighing on sentiment is market chatter pointing to the possibility of a slower policy response from
Read moreSmith & Nephew CFO off to Reckitt
17th Sep 2012 07:44
Medical technology business Smith & Nephew has lost its Chief Financial Officer to consumer goods multi-national Reckitt Benckiser. Adrian Hennah will leave the company at the end of December, with the search for his successor already underway. Chief Executive Olivier Bohuon thanked Hennab for his
Read moreMonday broker round-up
10th Sep 2012 09:13
Barclays: UBS raises target from 205p to 235p, buy rating unchanged. Chariot Oil & Gas: Peel Hunt downgrades to sell, target cut from 150p to 40p; Merchant Securities downgrades to sell, target cut from 232p to 29p. Debenhams: Seymour Pierce raises target from 80p to 100p, hold rating kept. Euras
Read moreWednesday broker round-up
15th Aug 2012 09:47
AB Foods: UBS raises target from 1,330p to 1,400p, buy rating unchanged. AVEVA: Jefferies ups target from 1,800p to 2,300p, buy recommendation maintained. Balfour Beatty: Investec maintains sell rating and 210p target. CLS Holdings: Peel Hunt ups target from 639p to 720p, hold rating kept. CRH:
Read moreBroker tips: RBS, Smith and Nephew, Ophir
3rd Aug 2012 11:12
Investec has reiterated its 'buy' recommendation and 300p target price for part-nationalised lender Royal Bank of Scotland after the group's in-line first-half results, saying that it expects a recovery in profitability from next year onwards. "It's not all bad. While MPs and regulators focus their
Read moreBroker snap: Smith and Nephew making strategic progress
3rd Aug 2012 11:09
Jefferies has raised its target price for medical devices maker Smith and Nephew from 740p to 780p and reiterated its 'buy' rating for the stock, saying that the group's first-half results showed that progress is being made on its strategic priorities. "Smith & Nephew's 1H results demonstrated prog
Read more